THE HALF-LIFE OF ENDOGENOUS INSULIN AND C-PEPTIDE IN MAN ASSESSED BY SOMATOSTATIN SUPPRESSION
THE HALF-LIFE OF ENDOGENOUS INSULIN AND C-PEPTIDE IN MAN ASSESSED BY SOMATOSTATIN SUPPRESSION
复制标题
DOI:
10.1111/j.1365-2265.1985.tb00185.x
复制
发表时间:
1985-01-01
影响因子:
3.2
通讯作者:
TURNER, RC
中科院分区:
文献类型:
--
作者:
MATTHEWS, DR;RUDENSKI, AS;TURNER, RC
The in-vivo half-lives of insulin and C-peptide were assessed in normal man by a method which examines the decline of endogenously produced insulin and C-peptide after somatostatin suppression of secretion. Venous blood samples were taken each minute from 7 normal subjects: i.v. glucose (0.1 g/kg ideal body wt) was given over 1 min to stimulate secretion, followed by a bolus of 250 .mu.g of somatostatin-14 and an infusion of a further 250 .mu.g somatostatin-14 over the subsequent 30 min. Plasma samples were analyzed for C-peptide, glucose and insulin. The initial mono-exponential half-lives over 8 min were 3.9 .+-. 0.3 and 10.2 .+-. 0.7 min respectively (mean .+-. SEM [standard error of the mean]) with subsequent slower declines. Log transformed insulin and C-peptide yielded biphasic declinations which were assessed by a 2-pool model. The rate constant of clearance of insulin implied avid uptake, while the kinetics of C-peptide clearance were slower and irreversible loss might be explained by glomerular filtration alone. The somatostatin suppression method of measuring hormone kinetics could be used for newly described hormones which are not available for in-vivo studies.